Literature DB >> 14636335

Involvement of gap junctions in the manifestation and control of the duration of seizures in rats in vivo.

Zita Gajda1, Erika Gyengési, Edit Hermesz, K Said Ali, Magdolna Szente.   

Abstract

PURPOSE: The possible role of gap junctions in the manifestation and control of the duration of seizures was tested on the 4-aminopyridine-induced epilepsy model in rats in vivo, by using electrophysiologic, pharmacologic, and molecular biologic techniques. METHODS; In electrophysiologic experiments, the functional states of the gap junctions were manipulated with a specific blocker (carbenoxolone) or opener (trimethylamine) at the already active focus of adult, anesthetized rats, 60 min after the induction of the first seizure, which was repeated spontaneously thereafter. Semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) amplification was used to measure the levels of connexin (Cx) 32, 43, and 36 messenger RNAs (mRNAs) prepared from the areas of the already active primary and mirror foci.
RESULTS: After repeated seizures, the expression levels of Cx32, Cx43, and Cx36 mRNAs at the epileptic foci were increased significantly. Blockade of the gap junctions with carbenoxolone shortened the duration of seizures and decreased the amplitude of the seizure discharges, whereas their opening with trimethylamine lengthened the duration and increased the amplitude. Secondary epileptogenesis was facilitated when the gap junctions were opened. CONCLUSIONS; Our findings support the idea that, in epileptic foci, the gap junctions are involved in the expression of rhythmic ictal discharges and in the control of the duration and propagation of the individual seizures in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636335     DOI: 10.1111/j.0013-9580.2003.25803.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  48 in total

Review 1.  Novel model for the mechanisms of glutamate-dependent excitotoxicity: role of neuronal gap junctions.

Authors:  Andrei B Belousov
Journal:  Brain Res       Date:  2012-07-05       Impact factor: 3.252

2.  Interneurons spark seizure-like activity in the entorhinal cortex.

Authors:  Maxime Lévesque; Rochelle Herrington; Shabnam Hamidi; Massimo Avoli
Journal:  Neurobiol Dis       Date:  2015-12-22       Impact factor: 5.996

3.  Closing the gap: electrotonic junctions in seizure control.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Sep-Oct       Impact factor: 7.500

4.  Propagation of postsynaptic currents and potentials via gap junctions in GABAergic networks of the rat hippocampus.

Authors:  Veronika Zsiros; Ildiko Aradi; Gianmaria Maccaferri
Journal:  J Physiol       Date:  2006-11-16       Impact factor: 5.182

5.  Protective effects of carbenoxolone are associated with attenuation of oxidative stress in ischemic brain injury.

Authors:  Lang Zhang; Yu-Min Li; Yu-Hong Jing; Shao-Yu Wang; Yan-Feng Song; Jie Yin
Journal:  Neurosci Bull       Date:  2013-05-07       Impact factor: 5.203

Review 6.  Neuronal gap junction coupling as the primary determinant of the extent of glutamate-mediated excitotoxicity.

Authors:  Andrei B Belousov; Joseph D Fontes
Journal:  J Neural Transm (Vienna)       Date:  2013-11-01       Impact factor: 3.575

7.  Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats.

Authors:  Jian-Dong Sun; Yan Liu; Yu-He Yuan; Jing Li; Nai-Hong Chen
Journal:  Neuropsychopharmacology       Date:  2011-12-21       Impact factor: 7.853

Review 8.  Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system.

Authors:  Maksymilian Onyszkiewicz; Kinga Jaworska; Marcin Ufnal
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-16

Review 9.  Role of gap junctions in epilepsy.

Authors:  Miao-Miao Jin; Zhong Chen
Journal:  Neurosci Bull       Date:  2011-12       Impact factor: 5.203

10.  Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex.

Authors:  Lin Xu; Ling-Hui Zeng; Michael Wong
Journal:  Neurobiol Dis       Date:  2009-05       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.